Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia
Clinical trial NCT05891847 · TERMINATED
Trial details
- NCT number
- NCT05891847
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-21
- Primary completion
- 2025-07-11
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.